Journal of Nanobiotechnology, 2022 · DOI: 10.1186/s12951-022-01752-8 · Published: December 28, 2022
The tumor microenvironment, characterized by hypoxia and high lactic acid accumulation, promotes tumor development. This study introduces CaO2-loaded nanoparticles to simultaneously regulate both acidic and hypoxic conditions. CaO2-loaded mesoporous polydopamine nanoparticles modified with sodium hyaluronate (CaO2@mPDA-SH) accumulate in the tumor site, consuming lactic acid and generating oxygen in the acidic microenvironment, thus remodeling the tumor microenvironment. By alleviating hypoxia, the nanoparticles further reduce lactate production by down-regulating HIF-1α and glycolysis-associated enzymes, efficiently repressing tumor progression through immune activation, anti-metastasis, and anti-angiogenesis.
The CaO2@mPDA-SH nanoparticles offer a new method for tumor treatment by simultaneously targeting the acidic and hypoxic microenvironment.
By promoting immune activation and reducing immunosuppressive factors, the nanoparticles enhance the effectiveness of immunotherapy.
The lactate-depleting action of the nanoparticles can reduce tumor metastasis and angiogenesis, improving patient outcomes.